Developing new treatments and prevention methods for HIV and related conditions
Official title: Expertise in the Product Development Lifecycle
Funded at Advanced Bioscience Laboratories, INC. · NIH-11180735 · Data updated 2026-11-12
This study is working on creating new treatments and prevention options for HIV that could also help with other infections and include birth control, so that patients can have access to better care and innovative solutions.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Advanced Bioscience Laboratories, INC. NIH-funded |
| Lab location | 1 site (Kensington, United States) |
| Project start | September 1, 2024 |
| Project end | August 31, 2030 |
| Funding year | 2024 |
| Award (this year) | $536,931 |
| NIH project number | 75N93023D00001-0-759302400006-1 |
| Project ID | NIH-11180735 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research include individuals at risk for HIV or those living with HIV, particularly those who may also face co-infections.
✕Less likely to help
Patients who are not at risk for HIV or do not have HIV-related health issues may not receive direct benefits from this research.
What this research studies
This research aims to support the development of new therapeutics and prevention products for HIV, including those that may also address co-infections and incorporate contraceptive methods. By providing essential resources and expertise, the project will help advance promising candidate products from early formulation stages through to clinical testing and regulatory approval. Patients may benefit from innovative treatments that emerge from this collaborative effort between researchers and private sector partners.
Why it matters
Potential benefit: If successful, this research could lead to new and effective treatments and prevention strategies for HIV and related health issues.
How similar studies have gone: Previous research has shown success in developing HIV treatments and prevention methods, indicating that this approach has the potential for meaningful advancements.
Where this research is happening
-
Advanced Bioscience Laboratories, INC.
Kensington, United States Active
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.